A. Mariotto
Ca · 2006–2022
A researcher in the Science corpus: 16 papers; trusts 0 researchers and is trusted by 4 researchers here, as inferred from the citation graph.
Who trusts A. Mariotto overall
Papers from A. Mariotto's perspective
Ordered by how strongly the researchers A. Mariotto trusts endorse each paper. Same corpus, a different order for every researcher.
- SEER Cancer Statistics Review, 1975-2003
- Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. (Journal of the National Cancer Institute)
- Projections of the cost of cancer care in the United States: 2010-2020. (Journal of the National Cancer Institute)
- Cost of care for elderly cancer patients in the United States. (Journal of the National Cancer Institute)
- Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. (Journal of the National Cancer Institute)
- Cancer survivors in the United States: age, health, and disability. (The journals of gerontology. Series A, Biological sciences and medical sciences)
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
- Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. (Journal of Clinical Oncology)
- Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis (Cancer)
- Annual Report to the Nation on the Status of Cancer, 1975–2012, Featuring the Increasing Incidence of Liver Cancer (Cancer)
Their papers
- Projections of the cost of cancer care in the United States: 2010-2020. (2011) — 2,505 citations
- Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival (2017) — 1,433 citations
- Cancer treatment and survivorship statistics, 2022 (2022) — 2,458 citations
- Cost of care for elderly cancer patients in the United States. (2008) — 708 citations
- The Effect of Advances in Lung-Cancer Treatment on Population Mortality (2020) — 1,262 citations
- Cancer treatment and survivorship statistics, 2019 (2019) — 3,837 citations
- Anticipating the ‘Silver Tsunami’: Prevalence Trajectories and Co-Morbidity Burden Among Older Cancer Survivors in the United States (2016) — 939 citations
- Cancer treatment and survivorship statistics, 2016 (2016) — 5,540 citations
- Cancer treatment and survivorship statistics, 2014 (2014) — 2,461 citations
- Annual Report to the Nation on the Status of Cancer, 1975-2010, Featuring Prevalence of Comorbidity and Impact on Survival among Persons with Lung, Colorectal, Breast or Prostate Cancer (2013) — 1,651 citations
- Cancer Survivors in the United States: Prevalence across the Survivorship Trajectory and Implications for Care (2013) — 637 citations
- SEER Cancer Statistics Review, 1975–2009 (Vintage 2009 Populations) (2012) — 1,400 citations
- Cancer treatment and survivorship statistics, 2012 (2012) — 3,165 citations
- Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. (2009) — 817 citations
- SEER Cancer Statistics Review, 1975-2003 (2006) — 9,332 citations
- SEER Cancer Statistics Review, 1975-2003, National Cancer Institute. Bethesda, MD, (2006) — 1,378 citations